BroadOak Logo

BioInformatics Acquires Kalorama Information

BioInformatics, a BroadOak portfolio company, acquires Kalorama Information, a leading market research publisher focused on the in vitro diagnostics, biotechnology, healthcare, medical device, and pharmaceutical markets.

The full press release is below.

BioInformatics Inc. Acquires Kalorama Information, Further Solidifying a Leadership Position in the Life Science, Diagnostics, and Imaging Markets

ARLINGTON, VA. (PRWEB) NOVEMBER 01, 2018: For more than 20 years, Kalorama Information, a division of, has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals.

“The Kalorama name has become the marquee brand in the Life Sciences and Diagnostics space and we couldn’t be more proud of it,” said Rob Granader, CEO and founder of and its publishing division. “I named the brand 20 years ago after the area where I was living at the time, and it has served the marketplace well.” Kalorama is a Greek word meaning beautiful vista and is a neighborhood in the Northwest quadrant of Washington, DC.

“Kalorama Information is a premier source of high-quality market research reports for corporate decision makers in the clinical diagnostics and life science space,” says Craig Overpeck, CEO of BioInformatics. “This acquisition further solidifies our leadership position in the life science, diagnostics, and imaging markets while presenting us with exciting opportunities in adjacent healthcare markets including medical device, pharma, and biotech.”

Under the terms of the deal, will continue selling Kalorama’s reports for BioInformatics including subscription Knowledge Centers, through Profound, and academic bundles.

“The convergence of science and medicine is ushering in the era of personalized medicine and our clients are expanding into new areas,” commented Overpeck, “Our latest acquisition shows our determination to be at the center of this transformation with both actionable market intelligence and innovative marketing opportunities for life science companies.”

Original Press Release